Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Nature Communications
|
September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia
Jessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.
Blood
|
May 31, 2012
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML
Bing Z Carter, Yihua Qiu, Xuelin Huang, et al.
Blood
|
November 2, 2006
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Michele Milella, Marina Konopleva, Cristina M Precupanu, et al.
Oncotarget
|
September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
Xin Chen, Xianping Shi, Chong Zhao, et al.
Cell Death & Disease
|
August 29, 2023
Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia
Chendi Xie, Hui Zhou, Dongmei Qin, et al.
Journal of the National Cancer Institute
|
February 15, 2014
Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents
Bing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Blood Cancer Journal
|
April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood Cancer Journal
|
May 16, 2023
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Molecular Cancer Therapeutics
|
April 1, 2022
Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem Cells
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood
|
July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia
Bing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Nature Communications
|
September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia
Jessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.
Blood
|
May 31, 2012
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML
Bing Z Carter, Yihua Qiu, Xuelin Huang, et al.
Blood
|
November 2, 2006
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Michele Milella, Marina Konopleva, Cristina M Precupanu, et al.
Oncotarget
|
September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
Xin Chen, Xianping Shi, Chong Zhao, et al.
Cell Death & Disease
|
August 29, 2023
Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia
Chendi Xie, Hui Zhou, Dongmei Qin, et al.
Journal of the National Cancer Institute
|
February 15, 2014
Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents
Bing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Blood Cancer Journal
|
April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood Cancer Journal
|
May 16, 2023
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Molecular Cancer Therapeutics
|
April 1, 2022
Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem Cells
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood
|
July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia
Bing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Page
of 8